Factors involved in treatment durability and immunological recovery in a cohort of HIV-positive patients receiving atazanavir-based regimens

INTRODUCTION: Since antiretroviral therapy must be taken lifelong, persistence and safety have become the goals to achieve. Protease inhibitors, in particular atazanavir (ATV) with or without ritonavir (r), represent a highly prescribed class in real life long-term treatment. METHODS: We conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales: Giacomelli, Andrea, Oreni, Letizia, Franzetti, Marco, Di Cristo, Valentina, Vergani, Barbara, Morosi, Manuela, Colella, Elisa, Galli, Massimo, Rusconi, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P298
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225322/
https://www.ncbi.nlm.nih.gov/pubmed/25397574
http://dx.doi.org/10.7448/IAS.17.4.19830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225322/
https://www.ncbi.nlm.nih.gov/pubmed/25397574
http://dx.doi.org/10.7448/IAS.17.4.19830

Ejemplares similares